JP notification on electronic study data (2024)
Notification on Handling of Submission of Electronic Study Data for New Drug Applications
Current edition
Notification of April 8, 2024
Current edition
Notification of April 8, 2024
About this standard
Requires clinical study data for new drug applications to be sent to the agency in electronic form, and says which products and data are covered.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Japan
- CTD, eCTD and electronic study dataDossier format · Not stated
Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, M4(R4), M4Q(R1), M4Q(R2), M4S(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.